Literature DB >> 3459510

The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.

N A Habib, M J Hershman, F Haberland, L Papp, C B Wood, R C Williamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3459510      PMCID： PMC2001389          DOI： 10.1038/bjc.1986.116

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

Review 1.  Progress report. Cancer of the pancreas.

Authors:  R G Morgan; K G Wormsley
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

2.  The rising incidence of carcinoma of the pancreas--real or apparent?

Authors:  L S Krain
Journal:  J Surg Oncol       Date:  1970       Impact factor: 3.454

3.  Epidemiology of pancreatic cancer.

Authors:  L Gordis; E B Gold
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

4.  The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer.

Authors:  N Zamcheck
Journal:  Clin Gastroenterol       Date:  1976-09

5.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.

Authors:  J Holmgren; L Lindholm; B Persson; T Lagergård; O Nilsson; L Svennerholm; C M Rudenstam; B Unsgaard; F Yngvason; S Pettersson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

6.  Pancreatic cancer: an overview of epidemiology, clinical presentation, and diagnosis.

Authors:  J R Malagelada
Journal:  Mayo Clin Proc       Date:  1979-07       Impact factor: 7.616

7.  Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides.

Authors:  L Lindholm; J Holmgren; L Svennerholm; P Fredman; O Nilsson; B Persson; H Myrvold; T Lagergård
Journal:  Int Arch Allergy Appl Immunol       Date:  1983
  7 in total
  6 in total

Review 1.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988-05

2.  Pancreatic cancer: the greatest oncological challenge.

Authors:  R C Williamson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-13

3.  CAM 17.1--a new diagnostic marker in pancreatic cancer.

Authors:  F Gansauge; S Gansauge; N Parker; M I Beger; B Poch; K H Link; F Safi; H G Beger
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer.

Authors:  C K Ching; J M Rhodes
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

5.  Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.

Authors:  P Kuusela; C Haglund; P J Roberts
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

6.  Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.

Authors:  P A Pasanen; M Eskelinen; K Partanen; P Pikkarainen; I Penttilä; E Alhava
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.